By Jacqueline Bell ( July 6, 2011, 12:55 PM EDT) -- The European Commission released a report Wednesday showing that the use of so-called pay-for-delay settlements between brand-name drugmakers and generics companies continues to decline, dropping to 3 percent of the industry's patent settlements last year....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.